Essex Bio-Technology Announces 2022 Annual Financial Results Mar 08, 2023 20:28 HKT | |
|
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration Feb 22, 2023 18:48 HKT | |
|
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar Feb 15, 2023 09:00 HKT | |
|
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases Feb 10, 2023 21:06 HKT | |
|
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific Feb 10, 2023 19:00 HKT | |
|
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW Feb 03, 2023 13:00 HKT | |
|
Novotech Acquires US-based Drug Development Consulting Firm, CBR International Jan 12, 2023 15:00 HKT | |
|
Novotech Acquires European CRO, Strengthens Global Operations Jan 12, 2023 15:00 HKT | |
|
HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study) Jan 11, 2023 21:00 HKT | |
|
Avance Clinical Celebrates GlobalReady Success as 40 Biotechs Join Program Jan 11, 2023 15:00 HKT | |
|
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations Jan 05, 2023 18:00 HKT | |
|
Novotech is Gold Sponsor at Biotech Showcase 2023 Dec 20, 2022 11:00 HKT | |
|
Data Shows 50% of New Trials Have Sites in Asia Pacific Dec 15, 2022 10:00 HKT | |
|
Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding Dec 14, 2022 21:45 HKT | |
|
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials Dec 06, 2022 11:00 HKT | |
|
AJG Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis Nov 17, 2022 08:00 HKT | |
|
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy Nov 11, 2022 17:00 HKT | |
|
Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper Oct 25, 2022 18:00 HKT | |
|
AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program Oct 18, 2022 07:00 HKT | |
|
The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval Oct 17, 2022 11:00 HKT | |
|